HGH1

Chr 8

HGH1 cochaperone

Also known as: BRP16, BRP16L, C8orf30A, C8orf30B, FAM203A, FAM203B

0
Active trials
3
Pubs (1 yr)
0
P/LP submissions
P/LP missense
1.69
LOEUF
GOF
Mechanism· predicted
Clinical SummaryHGH1
Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.69LOEUF
pLI 0.012
Z-score 0.51
OE 0.73 (0.331.69)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.32Z-score
OE missense 1.17 (0.891.55)
34 obs / 29.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.73 (0.331.69)
00.351.4
Missense OE1.17 (0.891.55)
00.61.4
Synonymous OE0.94
01.21.6
LoF obs/exp: 3 / 4.1Missense obs/exp: 34 / 29.1Syn Z: 0.17
DN
0.5672th %ile
GOF
0.75top 25%
LOF
0.2872th %ile

The highest-scoring mechanism for this gene is gain-of-function.

GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

HGH1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC